Drug Type Small molecule drug |
Synonyms HP 560, HP560 |
Target |
Action inhibitors |
Mechanism BET inhibitors(Bromodomain and extra terminal domain protein inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myelofibrosis | IND Approval | China | 23 Jul 2024 | |
| Hematologic Neoplasms | Preclinical | China | 05 Sep 2023 | |
| Multiple Myeloma | Preclinical | China | 05 Sep 2023 | |
| Triple Negative Breast Cancer | Preclinical | China | 05 Sep 2023 |





